Total Payments
$962.18
2024 Payments
$261.96
Companies
9
Transactions
47
Medicare Patients
299
Medicare Billing
$104,772
Payment Breakdown by Category
Food & Beverage$962.18 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $962.18 | 47 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $363.16 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $164.51 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $108.75 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $101.40 | 4 | $0 (2024) |
| Eisai Inc. | $68.10 | 3 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $53.86 | 2 | $0 (2021) |
| Vifor Pharma, Inc. | $42.67 | 3 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $31.99 | 1 | $0 (2024) |
| Madrigal Pharmaceuticals | $27.74 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $261.96 | 12 | ABBVIE INC. ($126.82) |
| 2023 | $211.44 | 9 | Alexion Pharmaceuticals, Inc. ($84.80) |
| 2022 | $306.90 | 17 | ABBVIE INC. ($126.38) |
| 2021 | $181.88 | 9 | AbbVie Inc. ($57.67) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: LIVER DISEASE | ||||||
| 10/28/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: LIVER DISEASE | ||||||
| 09/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: CRITICAL CARE | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/01/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Infectious Diseases | ||||||
| 03/19/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/28/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/16/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 01/10/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/01/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/03/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Rare Disease | ||||||
| 09/12/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/09/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Rare Disease | ||||||
| 07/17/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $29.35 | General |
| Category: Infectious Diseases | ||||||
| 07/10/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/25/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: VIROLOGY | ||||||
| 05/02/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/26/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Rare Disease | ||||||
| 12/13/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Rare Disease | ||||||
| 11/29/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/27/2022 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Infectious Diseases | ||||||
| 09/06/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 63 | 226 | $115,134 | $25,303 |
| 2022 | 1 | 47 | 120 | $80,440 | $18,095 |
| 2021 | 2 | 94 | 286 | $176,938 | $41,187 |
| 2020 | 2 | 95 | 160 | $87,688 | $20,187 |
Total Patients
299
Total Services
792
Medicare Billing
$104,772
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 46 | 160 | $107,544 | $23,046 | 21.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 66 | $7,590 | $2,257 | 29.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 47 | 120 | $80,440 | $18,095 | 22.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 73 | 255 | $166,770 | $38,872 | 23.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 21 | 31 | $10,168 | $2,315 | 22.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 68 | 109 | $70,960 | $16,322 | 23.0% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 27 | 51 | $16,728 | $3,865 | 23.1% |
About Brittney Turner, NP
Brittney Turner, NP is a Acute Care healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1831756766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brittney Turner, NP has received a total of $962.18 in payments from pharmaceutical and medical device companies, with $261.96 received in 2024. These payments were reported across 47 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($962.18).
As a Medicare-enrolled provider, Turner has provided services to 299 Medicare beneficiaries, totaling 792 services with total Medicare billing of $104,772. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Houston, TX
- Active Since 05/27/2019
- Last Updated 05/27/2019
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1831756766
Products in Payments
- AVYCAZ (Drug) $245.29
- DIFICID (Drug) $140.59
- ULTOMIRIS (Biological) $108.75
- Cresemba (Drug) $101.40
- TEFLARO (Drug) $97.02
- Lenvima (Drug) $68.10
- GATTEX (Drug) $53.86
- Veltassa (Drug) $42.67
- TERLIVAZ (Drug) $31.99
- RESMETIROM (Drug) $27.74
- RECARBRIO (Drug) $23.92
- MAVYRET (Drug) $20.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Houston
Afton Dickerson, Np, NP
Acute Care — Payments: $22,968
Acute Care $22,968
Michelle Johnston, Acnp, ACNP
Acute Care — Payments: $14,879
Acute Care $14,879
Amanda Bergeron, Agacnp, AGACNP
Acute Care — Payments: $11,628
Acute Care $11,628
Nicole Ona, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $10,247
Acute Care $10,247
Miss. Brittney Richard, Acnp, ACNP
Acute Care — Payments: $9,804
Acute Care $9,804
Meagan Chavarria, Np, NP
Acute Care — Payments: $8,988
Acute Care $8,988